Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Given Average Recommendation of “Buy” by Brokerages
Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) have received a consensus recommendation of “Buy” from the seventeen research firms that are currently covering the company, MarketBeat Ratings reports. Five analysts have rated the stock with a hold recommendation, ten have given a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $58.00.
A number of research firms have recently weighed in on ACHC. Mizuho raised their target price on Acadia Healthcare from $57.00 to $60.00 and gave the company a “buy” rating in a report on Friday, July 28th. UBS AG restated a “positive” rating and issued a $60.00 target price (up previously from $54.00) on shares of Acadia Healthcare in a report on Monday, July 31st. Jefferies Group LLC restated a “buy” rating on shares of Acadia Healthcare in a report on Friday, May 5th. BidaskClub upgraded Acadia Healthcare from a “sell” rating to a “hold” rating in a report on Saturday, June 10th. Finally, Deutsche Bank AG lifted their price target on Acadia Healthcare from $58.00 to $60.00 and gave the stock a “buy” rating in a report on Monday, July 31st.
Acadia Healthcare (ACHC) opened at 52.27 on Friday. The company has a 50-day moving average of $49.45 and a 200-day moving average of $44.19. The company has a market cap of $4.59 billion, a price-to-earnings ratio of 574.40 and a beta of 1.15. Acadia Healthcare has a 12 month low of $32.54 and a 12 month high of $54.73.
Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Thursday, July 27th. The company reported $0.66 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.65 by $0.01. Acadia Healthcare had a return on equity of 8.69% and a net margin of 0.30%. The company had revenue of $715.90 million for the quarter, compared to analyst estimates of $717.38 million. During the same quarter last year, the company earned $0.73 earnings per share. The company’s revenue for the quarter was down 5.4% on a year-over-year basis. Analysts predict that Acadia Healthcare will post $2.45 EPS for the current year.
In related news, insider Scott Schwieger sold 2,891 shares of the business’s stock in a transaction dated Monday, July 31st. The stock was sold at an average price of $52.85, for a total transaction of $152,789.35. Following the completion of the transaction, the insider now directly owns 8,841 shares in the company, valued at $467,246.85. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director Reeve B. Waud sold 50,000 shares of the business’s stock in a transaction dated Friday, June 9th. The stock was sold at an average price of $45.09, for a total value of $2,254,500.00. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 2,136,347 shares of company stock valued at $105,383,249. 11.10% of the stock is owned by company insiders.
Large investors have recently modified their holdings of the company. BlackRock Inc. raised its stake in shares of Acadia Healthcare by 27,497.3% in the first quarter. BlackRock Inc. now owns 5,145,786 shares of the company’s stock valued at $224,356,000 after buying an additional 5,127,140 shares during the period. Aristotle Capital Management LLC bought a new stake in Acadia Healthcare during the first quarter worth $140,071,000. William Blair Investment Management LLC raised its stake in Acadia Healthcare by 1,247.4% in the second quarter. William Blair Investment Management LLC now owns 2,128,972 shares of the company’s stock worth $105,129,000 after buying an additional 1,970,965 shares during the period. FMR LLC raised its stake in Acadia Healthcare by 173.2% in the first quarter. FMR LLC now owns 2,195,002 shares of the company’s stock worth $95,702,000 after buying an additional 1,391,552 shares during the period. Finally, Frontier Capital Management Co. LLC raised its stake in Acadia Healthcare by 112.2% in the first quarter. Frontier Capital Management Co. LLC now owns 2,087,088 shares of the company’s stock worth $90,997,000 after buying an additional 1,103,446 shares during the period.
ILLEGAL ACTIVITY NOTICE: “Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Given Average Recommendation of “Buy” by Brokerages” was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this news story on another publication, it was stolen and reposted in violation of international trademark and copyright legislation. The correct version of this news story can be read at https://www.thecerbatgem.com/2017/08/09/acadia-healthcare-company-inc-nasdaqachc-given-consensus-rating-of-buy-by-analysts-updated.html.
About Acadia Healthcare
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Receive News & Stock Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related stocks with our FREE daily email newsletter.